As the number of children diagnosed with autism skyrockets, people continue to debate the cause of the spectrum disorder altogether. Some people learn towards the cause being found in genetics, some lean towards the environment, and many blame various vaccines given to children within the first years of their lives, such as the Measles, Mumps, Rubella (MMR) vaccine. A year ago, a mercury-based component that mimicked the USA banned drug, Thiomersal, ignited controversy, as it was an active ingredient in the H1N1 vaccine. Now, a year later, in autism, we are all left at a new crossroad. What causes this spectrum disorder that one in 91 children are affected by?
According to industry professionals, one setback in finding the cause of autism comes from repeated and simultaneous studies and a need for a unified system of research. Industry professionals have been vying for the chance to connect in a more efficient way. Now, numbers have jumped up 59% in only the last few years. Parents of today, live with the greatest fear, as they are unable to protect their child from something that science cannot identify the reason behind, let alone a cure.
In Israel, on July 5-6, Jerusalem’s Ramada- Renaissance Hotel will welcome the connective platform for 30 autism experts, at the 2010 International Autism Conference. At the event, the hot-button topic of Neuropsychopharmacology, how drugs can relate to the mind, will be fully covered by Dr. Eric Hollander. Dr. Eli Hatchwell, Director the Genomics Core Facility at Stony Brook University (NY-USA) will speak on “Modern Approaches to the Study of the Genetics of Autism.” This topic will dive into a variation of topics but also the core issue of the potential of genetics being linked to autism.
Ruth Amber Gristak is the Chief of Staff for the International Center for Autism Research and Education, Inc. (ICare4Autism). For more information on this organization, please visit www.icare4autism.org.
Visit the official website of the 2010 International Autism Conference